MedTrace Logo

Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method

NCT02664246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2016-01-27

No results posted yet for this study

Summary

This review article have included about ten thousand patients undergoing percutaneous coronary intervention (PCI), aim to identify the incidence of CIN in actual, find some new risk factors and the protecting methods for these factors.

Conditions

  • Cardio-Renal Syndrome

Interventions

DEVICE

percutaneous coronary intervention

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Dai Yun Chen, MD · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02664246 on ClinicalTrials.gov